No business profile yet.
Size Optima Health (OPT.L) is a United Kingdom Industrials company (Miscellaneous Commercial Services) with a market value of $349M, the 336th largest of 355 United Kingdom companies the cockpit tracks. Shares closed at £244.00 on 18 Nov 2026.
Performance Over six months the shares gained 29.4%, against -21.0% for the median peer and +0.1% for the United Kingdom market (cap-weighted) — 2nd highest of 21 in its peer set.
Growth Revenue grew 14.8% over the last twelve months (peer median +4.2%); the operating margin is 3.3% (peer median 6.5%).
Valuation It trades at 18.6× forward earnings against a peer median of 18.6× (6th cheapest of 11).
Price implies For today's price to make sense, revenue must grow about 30% a year for seven years (Req g). Recent delivered growth is +2%, so the hurdle is +28 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 5.3 points below its cost of capital (6.6% WACC).
Next results Next results expected around 16 Dec 2026 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | £121M | £121M | £105M | £111M | £115M |
| Revenue growth | — | +15% | -5% | -4% | — |
| Gross profit | £28.6M | £28.6M | £26.7M | £25.7M | £26.7M |
| EBITDA | £15.2M | £15.2M | £17.6M | £18.2M | £20.8M |
| Net income | £1.40M | £1.40M | £1.65M | -£1.08M | £1.59M |
| Free cash flow | £13.2M | £13.2M | £451,000 | £12.4M | £4.86M |
| Capital expenditure | £3.13M | £3.13M | £3.75M | £2.85M | £4.20M |
| Total debt | n/a | £95.0M | £21.7M | £2.40M | £3.77M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | OPT.L | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | 0.0% | -3.5% | 8th highest of 21 |
| 6-month return | +29.4% | -21.0% | 2nd highest of 21 |
| Distance from 52-week high | -7.6% | -41.6% | 3rd highest of 21 |
| Revenue growth (TTM) | +14.8% | +4.2% | 6th highest of 21 |
| Operating margin | 3.3% | 6.5% | 8th lowest of 20 |
| Forward P/E | 18.6× | 18.6× | 6th cheapest of 11 |
| Growth the price implies (Req g, 7 yrs) | 29.8% | 3.9% | 2nd most demanding of 12 |
| Growth delivered (Del g) | +1.5% | +7.6% | 4th lowest of 12 |
| Hurdle (Req g minus delivered) | +28.3 pp | -7.1 pp | 2nd most demanding of 12 |
| ROIC minus cost of capital | -5.3 pp | -4.2 pp | 9th lowest of 20 |
| EV / EBITDA | 22.3× | 7.4× | most expensive of 10 |
| Net debt / EBITDA | 4.8× | 0.2× | 2nd most indebted of 12 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Optima Health OPT.L | United Kingdom | $349M | +29% | +15% | 3% | 18.6× | 29.8% | +1.5% |
| Medley 4480.T | Japan | $349M | -16% | +21% | 7% | 21.7× | 13.0% | +40.0% |
| Takara & 7921.T | Japan | $350M | +27% | +4% | 15% | n/a | -11.7% | +4.7% |
| Materials Analysis Technology 3587.TWO | Taiwan | $350M | -53% | +4% | 14% | 11.4× | 0.9% | +12.6% |
| Business Brain Showaota 9658.T | Japan | $344M | +63% | +5% | 7% | n/a | 0.5% | +7.6% |
| Hargreaves Services HSP.L | United Kingdom | $355M | +10% | +33% | 4% | 17.9× | 9.4% | +11.4% |
| Shenzhen Ridge Technology 300977.SZ | China | $342M | -31% | +20% | -3% | 31.2× | 42.0% | -4.0% |
| Tianjin LVYIN Landscape & Ecology Construction 002887.SZ | China | $341M | -48% | -8% | 12% | 16.2× | 10.6% | -13.0% |
| Pico Far East 0752.HK | Hong Kong | $341M | -10% | +3% | 6% | n/a | n/a | n/a |
| Beijing Kaiwen Education Technology 002659.SZ | China | $357M | -19% | +7% | 8% | 113.7× | 15.1% | +1.5% |
| Axactor ACR.OL | Norway | $340M | -19% | -146% | n/a | n/a | n/a | n/a |
| RattanIndia Enterprises RTNINDIA.NS | India | $359M | -28% | -3% | 1% | n/a | n/a | n/a |
| SMO ClinPlus 301257.SZ | China | $359M | -35% | 0% | 3% | 19.2× | n/a | n/a |
| Nanofilm Technologies International MZH.SI | Singapore | $339M | -50% | +10% | 8% | 21.6× | 3.9% | +2.3% |
| AbClon 174900.KS | South Korea | $360M | -40% | +45% | -337% | n/a | n/a | n/a |
| K-Bro Linen KBL.TO | Canada | $361M | -1% | +31% | 8% | 14.4× | 3.3% | +20.9% |
| YingTong Telecommunication 002861.SZ | China | $362M | -23% | +15% | -8% | n/a | n/a | n/a |
| Shanti Educational Initiatives SEIL.NS | India | $335M | -1% | -18% | 4% | n/a | n/a | n/a |
| Avacta AVCT.L | United Kingdom | $363M | -33% | -100% | -27,388% | n/a | n/a | n/a |
| SIGMAXYZ 6088.T | Japan | $334M | +9% | -13% | 24% | 11.6× | -8.1% | +11.2% |
| Pubang Landscape Architecture 002663.SZ | China | $364M | -36% | -25% | -24% | n/a | n/a | n/a |